Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term “proteins in decayed dentin” refers to the complex set of proteins present in dentin tissue that has undergone decay due to carious lesions. Dentin itself is a mineralized tissue located beneath the tooth enamel and consists primarily of type I collagen (~90% of organic content), along with non-collagenous proteins such as dentin phosphoprotein (DPP), dentin sialoprotein (DSP), proteoglycans, growth factors (e.g., TGF-β1, BMPs), and other matrix components[1][2][3][6]. In the context of decay, these proteins are released or denatured due to the action of bacterial proteases and host-derived proteases (such as matrix metalloproteinases and cathepsins), which break down the dentin matrix and contribute to cavity formation[1][7]. The decayed dentin does not contain a single unique protein target but rather a reservoir of matrix proteins and bioactive molecules, some of which can stimulate reparative processes in the pulp-dentin complex or participate in remineralization[2][3]. These proteins are important for tissue repair and regeneration studies but are not a distinct drug target, receptor, or enzyme.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteins in decayed dentin.